• MJHLS Brand Logo

© 2020 MJH Life Sciences™ and Cure Today. All rights reserved.

Leukemia | Tumor

Cancer May Not Suggest Poor Health Outcomes After COVID-19, Study Shows

November 16th 2020, 4:00pm

Article

A retrospective study of patients with COVID-19 showed that those with cancer were not more likely to experience severe symptoms or death due to the virus than those without cancer. Rather, only age and obesity were associated with poor COVID-19 outcomes.

Friday Frontline: A Father Receiving Treatment for Leukemia Surprises His Daughter on Her Wedding Day; ‘The Wanted’ Singer Tom Parker Diagnosed with Inoperable Brain Tumor; and More

October 16th 2020, 3:00pm

Article

From “The Wanted” singer Tom Parker announcing he has been diagnosed with stage 4 glioblastoma and is undergoing treatment, to a Houston-area father receiving treatment for leukemia surprising his daughter on her wedding day, here’s what’s happening in the cancer landscape this week.

Friday Frontline: Child Donates Proceeds from Selling Pumpkins to Local Cancer Charity, Cancer Researcher Sentenced to Prison for Stealing Research Funds, and More

October 9th 2020, 3:00pm

Article

From a child from Indiana donating funds from a pumpkin sale to a local cancer charity, to a researcher at Stony Brook University being sentenced to prison after stealing $225,000 in cancer research funds, here’s what’s happening in the cancer landscape this week.

Family of First Patient with Pediatric Cancer to Receive CAR-T Cell Therapy Opens Up About Treatment

October 8th 2020, 9:00pm

Article

Emily Whitehead’s family details her journey with cancer and how advocating for their daughter led to Emily’s extraordinary CAR-T cell therapy treatment.

Keeping Calm and Carrying on With CLL

October 5th 2020, 5:00pm

Article

CLL patient shares his experience with the disease and the importance of aiming to live his life to the fullest despite his diagnosis.

Expanding the Horizon for Hairy Cell Leukemia

September 7th 2020, 2:00pm

Video

CURE spoke with two physicians, on behalf of the Hairy Cell Leukemia Foundation, about the basics of the disease, as well as its diagnosis and treatment, and also about how patients can learn more about clinical trials.

FDA Grants Novel Treatment for Acute Myeloid Leukemia Fast Track Designation

August 5th 2020, 5:00pm

Article

The FDA’s fast track designation for BST-236 to treat adults aged 75 years or older with acute myeloid leukemia, or who have comorbidities that prevent the use of intensive induction chemotherapy, may open the doors to an accelerated approval.

Patient Assessment Tool May Provide Insight into Health-Related Quality of Life in AML

August 4th 2020, 7:00pm

Article

A patient assessment tool, known as the Functional Assessment of Cancer Therapy–Leukemia (FACT-Leu), was a viable and valid outcome measure for patients with acute myeloid leukemia not eligible for intensive therapy.

Possible Triplet Regimen Shows Promise For Certain Patients with Acute Myeloid Leukemia

August 4th 2020, 5:00pm

Article

“Overall, the take-home point is that it's a small study so far and the follow-up time is still short, but it is pretty exciting preliminary data,” said Dr. Courtney DiNardo about the combination of Tibsovo plus Venclexta – with or without Vidaza – in IDH1-mutated acute myeloid leukemia.

3 Drug Treatment Puts Some Patients With CLL On the Road to Remission

July 21st 2020, 10:00pm

Article

A three-drug treatment sparked complete responses in more than half of patients with high-risk chronic lymphocytic leukemia, who also tolerated the regimen well.

x